Anti-Inflammatory Effects: Reduces inflammation, which is beneficial in treating chronic inflammatory skin conditions
therefore, the final dose of Liraglutide and Lixisenatide was approximately 1.6 mg/day (DUAL II), 1.5 mg/day (DUAL V) and 17 g/day (Lixilan-L)
Conversely, abnormal blood glucose levels have been shown to elevate cancer risk and decrease survival rates in cancer patients [12, 50]
Skin & hair Acne/derm: benzoyl peroxide, clindamycin ( benzoyl peroxide), hydrocortisone, triamcinolone, betamethasone, ketoconazole, clotrimazole, fluconazole
El periodo medio de observacin fue de 16 meses